Advertisement
Advertisement
XAIR
Beyond Air, Inc. Common Stock
2.52
USDSponsored
+0.23
+10.28%
Nov 10, 15:59 UTC -5
Closed
After-Market
2.53
+0.01
+0.40%
Beyond Air, Inc. Common Stock (XAIR) Earnings
XAIR Earnings Reports
Positive Surprise Ratio
XAIR beat 14 of 33 last estimates.
42%
Next Report
Today AMC
Date of Next Report
Nov 11, 2026
Estimate for Q2 27 (Revenue/ EPS)
$3.57M
/-$2.58
Implied change from Q1 27 (Revenue/ EPS)
+101.92%
/-76.09%
Implied change from Q2 26 (Revenue/ EPS)
+96.37%
/-89.68%
Beyond Air, Inc. Common Stock earnings per share and revenue
On Aug 13, 2026, XAIR reported earnings of -10.79 USD per share (EPS) for Q1 27, beating the estimate of -2.79 USD, resulting in a 3.83% surprise. Revenue reached 1.77 million, compared to an expected 3.06 million, with a -30.67% difference. The market reacted with a +14.38% price change (close before vs. close after earnings).
Looking ahead to Q2 27, -- analysts forecast an EPS of -2.58 USD, with revenue projected to reach 3.57 million USD, implying an decrease of -76.09% EPS, and increase of 101.92% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
TELA Bio, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.16
Actual
-$0.13
Surprise
+20.54%
Atossa Therapeutics, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.90
Actual
-$0.56
Surprise
+38.31%
CalciMedica, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$1.30
Actual
-$0.72
Surprise
+44.64%
Scholar Rock Holding Corporation Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.86
Actual
-$0.81
Surprise
+6.18%
Kura Oncology, Inc.
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.83
Actual
-$0.78
Surprise
+7.00%
Olema Pharmaceuticals, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.63
Actual
-$0.73
Surprise
-14.53%
Autolus Therapeutics plc - ADR
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.16
Actual
-$0.21
Surprise
-27.20%
Protalix BioTherapeutics, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.03
Actual
$0.05
Surprise
+265.02%
PepGen Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.27
Actual
-$0.28
Surprise
-1.19%
Humacyte, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.07
Surprise
+22.91%
FAQ
What were Beyond Air, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2027?
For Q1 2027, Beyond Air, Inc. Common Stock reported EPS of -$10.79, beating estimates by 3.83%, and revenue of $1.77M, -30.67% below expectations.
How did the market react to Beyond Air, Inc. Common Stock's Q1 2027 earnings?
The stock price moved up 14.38%, changed from $6.05 before the earnings release to $6.92 the day after.
When is Beyond Air, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 11, 2026.
What are the forecasts for Beyond Air, Inc. Common Stock's next earnings report?
Based on --
analysts, Beyond Air, Inc. Common Stock is expected to report EPS of -$2.58 and revenue of $3.57M for Q2 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.